Table 2

Quantitative CMR parameters

	Patients with HCM	Healthy non-athletes	Healthy athletes
N	45	180	554
LV EF (%)	58±8.7	59±6.2***	56±5.1**
LV SV (ml/m²)	54±9.5***	55±8.6***	63±10^,*
LV EDV (ml/m²)	94±17***	94±13***	114±17^,*
LV ESV (ml/m²)	40±13***	39±8.9***	50±11^,*
LV EDM (g/m²)	74±23^,*	41±9.6^,**	53±13^,*
RV EF (%)	58±7.3^,*	54±5.9^,**	52±5.0^,*
RV SV (ml/m²)	51±10^,*	55±8.7^,**	63±10^,*
RV EDV (ml/m²)	90±22^,*	101±16^,**	123±21^,*
RV ESV (ml/m²)	39±14^,*	47±11^,**	60±14^,*
Septal wall thickness (mm)	21±4.5^,*	8.7±1.4^,**	9.6±1.6^,*
Ratio of LV EDV : EDM	1.30±0.33^,*	2.39±0.51^,**	2.25±0.43^,*
Ratio of LV EDV : RV EDV	1.10±0.21^,*	0.94±0.09*	0.93±0.07*

*p<0.05 versus patients with HCM.
**p<0.05 versus healthy non-athletes.
***p<0.05 versus healthy athletes.
CMR, cardiac MRI; EDM, end-diastolic mass; EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; HCM, hypertrophic cardiomyopathy; LV, left ventricular; RV, right ventricular; SV, stroke volume.